NCT02477033已完成1 期
A Placebo-controlled Cross-over Randomized Study to Investigate the Impact of Butyricicoccus Pullicaecorum in Healthy Human Volunteers
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- KU Leuven
- 入组人数
- 30
- 试验地点
- 2
- 主要终点
- Safety profile of Butyricicoccus pullicaecorum intake (composite outcome measure), measured by abdominal complaints surveys, standard blood tests and fecal calprotectin measurements
研究概览
简要总结
During this project the safety, tolerability and effect on gut microbiota of oral administration of Butyricicoccus pullicaecorum was investigated in healthy human volunteers by a placebo-controlled cross-over randomized study.
详细描述
Intervention periods were 4 weeks, with daily intake of 1 capsule. Wash-out periods were 3 weeks.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Basic Science
- 盲法
- Triple (Participant, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 60 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •BMI between 18 and 28 kg/m²
- •Good general health
- •Regular eating pattern (3 meals/day on at least 5 days/week)
排除标准
- •Chronic gastrointestinal disease (Crohn's disease, ulcerative colitis, irritable bowel syndrome, chronic constipation or chronic diarrhea)
- •Surgery of the gastrointestinal tract (except for an appendectomy)
- •Use of antibiotics during the month preceding the study
- •Use of medication or dietary supplements influencing gut transit or intestinal microbiota during the month preceding the study. Examples of such medication/dietary supplements are antispasmodics (e.g. buscopan), antidiarrheal medication (e.g. imodium), probiotic medication (e.g. lacteol, enterol)
- •Intake of pre- or probiotics during the study or during the month preceding the study
- •Being on a weight-loss diet during the study or during the month preceding the study
- •Extreme dietary habits (e.g. vegan, Atkins diet, Montignac diet)
- •Females who are pregnant, lactating or planning to become pregnant during the study period
结局指标
主要结局
Safety profile of Butyricicoccus pullicaecorum intake (composite outcome measure), measured by abdominal complaints surveys, standard blood tests and fecal calprotectin measurements
时间窗: 1 year
次要结局
- The effect of Butyricicoccus pullicaecorum intake on gut microbiota composition, measured by 16S rDNA Illumina profiling of the bacterial communities(1 year)
- The effect of Butyricicoccus pullicaecorum intake on gut microbiota activity, measured by GC-MS analysis of the fecal volatile organic compounds(1 year)
研究者
Kristin Verbeke
Professor Kristin Verbeke
KU Leuven
研究点 (2)
Loading locations...
相似试验
已完成
1 期
Melanoma Checkpoint and Gut Microbiome Alteration With Microbiome InterventionMetastatic MelanomaNCT03817125Parker Institute for Cancer Immunotherapy14
已完成
2 期
The GRAFT Study: Gut RecolonizAtion by Fecal TransplantationClostridium Difficile InfectionC.Difficile DiarrheaCDINCT03621657University of Wisconsin, Madison1
已完成
不适用
The Effects of a Novel Probiotic on Gastrointestinal Health in Generally Healthy AdultsGastrointestinal HealthImmune HealthDigestive HealthNCT05595980BIO-CAT Microbials, LLC80
招募中
1 期
R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid TumorsSolid Tumor, AdultSolid TumorBasal Cell CancerSquamous Cell CancerAdenomaMelanomaNCT06398418Rise Therapeutics LLC33
已完成
4 期
Disturbance of the Intestinal Microbiota by Temocillin vs Cefotaxime in Treatment of Febrile Urinary Tract InfectionsUrinary Tract InfectionsNCT02959957Håkan Hanberger157